The majority of respondents with more experience of a neurological disorder
said that they would want to know in spite of there being no cure.
Early intervention holds promise in treating childhood neurological disorder
The Society advocates the use of evidence-based practice strategies and promotes strategies to prevent neurological disorders
The scientists realized that laboratory-grown neurons might be useful for treating people with neurological disorders
What these statistics tell us is just how strongly people feel about tackling neurological disorders
like dementia, said Marc Wortmann, Executive Director of Alzheimer s Disease International.
Today, we have achieved the first milestone under our broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders
," said B.
Children who have the neurological disorder
, rarely diagnosed before they are 18 months old, can have extreme difficulty talking, make little or no eye contact, dislike being touched and show little desire or ability to communicate with others.
Diagnosing Alzheimer's disease, the progressive neurological disorder
, isn't easy, short of an autopsy.
Researchers have developed the first test for ``mad cow'' disease and its human form, a fatal neurological disorder
known as Creutzfeldt-Jakob disease (CJD).
The appearance of the neurological disorder
among only a portion of the parents and their children undermines a purely genetic explanation, say the researchers.
Previously, the team linked an amino acid in chickling peas (which are consumed in Africa and Asia, especially during famines) to a related neurological disorder
Epilepsy is the most common serious neurological disorder
in the world today, affecting fifty million children and adults around the world.
The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder
affecting approximately one percent of the population worldwide.
WASHINGTON, July 13, 2015 /PRNewswire-USNewswire/ -- America's biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders
, including epilepsy, Alzheimer's disease, multiple sclerosis (MS) and Parkinson's disease.
MRIGlobal declared that it has been given a $54 Million, 10-year program from the National Institute of Neurological Disorders
and Stroke to offer support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.